This process, through which certain neuropeptides induce vasodilation and increase vascular permeability, glandular activation, and leukocyte recruitment, particularly in the airway, was shown to have an important contributory role in airway inflammation and associated pathologies in animal models. 2 SP was identified as a key mediator of this process in guinea pigs because animals treated with capsaicin to deplete SP and animals treated with an SP antagonist did not have vagally induced neurogenic inflammation. 3 Neuropeptides and their respective receptors could be identified in human airways, 4, 5 and their release was shown to be induced by allergen 6 or hypertonic saline provocation. 7 However, the presence and relative contribution of neurogenic inflammation to human airway disease have been difficult to demonstrate, 8 suggesting an alternate clinically relevant role for neuropeptides.
Viruses are primarily recognized through their pathogenassociated molecular patterns by using the evolutionarily conserved family of Toll-like receptors (TLRs), of which TLR3, TLR4, TLR7, TLR8, and TLR9 are responsible for viral recognition. 9 Pathogen-associated molecular pattern recognition by TLRs is known to activate a signaling cascade that results in cytokine production, leading to recruitment of cells of the immune system. 10 Production of SP in response to viral infection of the airways is well established, 11, 12 with current research revealing a significant contribution of SP to the clinical symptoms of respiratory syncytial virus infection. 13 In addition, recent findings demonstrate the ability for neuropeptides to modulate the mechanisms of innate immunity. [14] [15] [16] However, early and local production of SP in response to viral invasion in the nose has not previously been studied.
Therefore, the present study was designed to investigate whether SP could be rapidly and locally released in response to a virus entering the nose and, if so, whether SP release could subsequently affect the local immune defense, as represented by mucosal TLR expression.
METHODS Animals
Six-week-old female C57BL/6N mice were obtained from Charles River (Sulzfeld, Germany). They were housed in plastic cages with adsorbent bedding in temperature and light/dark cycle (12-hour/12-hour)-controlled rooms. Food and water were available ad libitum. Animals were handled in accordance with the Federation for European Laboratory Animal Science Associations guidelines. All animal procedures were approved by the regional animal experimental ethical review board (ethical permit nos. N153-11 and N258-13).
Isolation and culture of trigeminal sensory neurons
Murine trigeminal ganglial neurons (TGNs) were isolated, as previously described, 17 with modifications. A full description of the isolation and culture procedure is provided in the Methods section in this article's Online Repository at www.jacionline.org.
Isolation and culture of human nasal epithelial cells
Human nasal epithelial cells (HNECs) from 9 healthy, nonallergic, nonsmoking subjects (3 male and 6 female subjects) were isolated by means of nasal brushing, as previously described. 18 Cells were maintained in collagen-coated tissue culture flasks in Keratinocyte Serum-Free Medium (KSFM; Gibco, Paisley, United Kingdom) supplemented with 0.005 mg/mL epidermal growth factor (Gibco), 0.05 mg/mL bovine pituitary extract (Gibco), 20 U/mL penicillin, 20 mg/mL streptomycin, and 0.25 mg/mL Fungizone (amphotericin B; complete KSFM). All cells were cultured in a humidified chamber at 378C with 5% CO 2 . Cells from passages 2 to 5 were used and were all positive for epithelial cell adhesion molecule (>90%), an epithelium-specific adhesion molecule.
Isolation and culture of murine nasal epithelial cells
Isolation of murine nasal epithelial cells (MNECs) was carried out, as previously described. 19 A full description of the isolation and culture procedure is provided in the Methods section in this article's Online Repository.
Cell stimulation
HNECs were seeded on 24-well culture plates (250,000 cells/well) in 1 mL of complete KSFM and incubated overnight. Cells were subsequently cultured for 15 minutes, 30 minutes, or 4 hours with R-837 (InvivoGen, San Diego, Calif) or R-848 (InvivoGen; both at 5, 10, 30, or 100 mg/mL). Cell-free supernatants were analyzed for SP release. Alternatively, cells were cultured for 30 minutes with SP (100 nmol/L; Sigma-Aldrich, St Louis, Mo) after a 3-minute preincubation with the neurokinin 1 receptor (NK1R) antagonist aprepitant (10 nmol/L; Selleckchem, Houston, Tex). Cells were analyzed for TLR expression by using flow cytometry.
MNECs were cultured with R-837 (5, 10, 30, or 100 mg/mL) for 15 minutes, 30 minutes, or 4 hours. Cell-free supernatants were analyzed for SP release.
TGNs were cultured with R-837 (5, 10, 30, or 100 mg/mL) for 15 minutes, 30 minutes, or 4 hours. Cell-free supernatants were analyzed for SP release.
Collection and immunohistochemistry of nasal biopsy specimens
Human nasal biopsy specimens from 5 healthy subjects were obtained in conjunction with nasal surgery (resection of the lower turbinate) or as previously described. 20 Biopsy specimens were postfixed in 4% paraformaldehyde embedded in paraffin and subsequently cut into 5-mm sections on a microtome. A full description of the immunohistochemistry procedure can be found in the Methods section in this article's Online Repository.
Collection and immunohistochemistry of human trigeminal ganglia
Trigeminal ganglia were a kind gift from Janos Tajti at the University of Szeged. They were obtained during autopsy from adult subjects in accordance with the University of Szeged medical school guidelines for ethics in human tissue experiments. Ganglia were obtained from 6 subjects (4 male and 2 female subjects) with an average age of 73 years. None of the patients had any central nervous system disease. Tissue was collected within 24 hours after death. A full description of the immunohistochemistry procedure can be found in the Methods section in this article's Online Repository. 
Flow cytometry

Stimulation, immunocytochemistry, and confocal microscopy of HNECs
HNECs were seeded onto 96-well IbiTreat m-plates (Ibidi GmbH, Martinsried, Germany) at 150,000 cells/mL in 300 mL of complete KSFM and incubated overnight. Cells were cultured for 30 minutes with SP (100 mmol/L) or media and subsequently fixed with 4% paraformaldehyde. A full description of the immunocytochemistry procedure can be found in the Methods section in this article's Online Repository. Imaging was performed with a Zeiss LSM800 confocal microscope (Zeiss, Oberkochen, Germany).
Immunocytochemistry of murine neurons
A full description of the immunohistochemistry procedure can be found in the Methods section in this article's Online Repository.
Measurement of SP
Levels of SP from cell-culture supernatants were measured with an SP EIA Kit, allowing detection of human and mouse SP (Cayman Chemical, Ann Arbor, Mich), according to the manufacturer's instructions.
Statistical analysis
Data were analyzed with GraphPad Prism software (GraphPad Software, San Diego, Calif). Results are expressed as individual dots with means or means 6 SEMs. In experiments involving human tissue, including biopsy specimens and cultured cells, n is equal to the number of subjects. In experiments involving cultured murine epithelial cells or neurons, n is equal to the number of individual replicate measurements. SP levels were analyzed by using a Kruskal-Wallis test (TGNs and MNECs) or a Friedman test (HNECs) for nonparametric data, followed by a Dunn multiple comparison posttest. TLR expression on HNECs was analyzed by using a repeated-measures ANOVA, followed by a Bonferroni multiple comparison posttest. A P value of .05 or less was considered statistically significant. 
Ethics statement
RESULTS TLR expression in the nasal mucosa
The presence of virus-recognizing TLRs in the upper airway was initially verified through immunohistochemical staining of nasal biopsy specimens from healthy subjects. Widespread expression of TLR3, TLR4, and TLR9 was evident (Fig 1, A, B , and D), whereas TLR7 expression was found to be limited to nerve fibers (Figs 1, C, and 2, B) and the nasal epithelium (Fig 2, A) . Neuronal TLR expression was further assessed by using cadaveric human trigeminal ganglia, demonstrating high expression of TLR7 and TLR9 (Fig 3, C and D) and low expression of TLR3 and TLR4 (Fig 3, A and B) . TLR7 expression was also shown to colocalize with SP on innervating nerve fibers in human nasal biopsy specimens (Fig 2, C) .
Because of the use of murine ganglia in subsequent functional experiments, expression of TLR7 was further investigated in murine ganglion cell cultures. TLR7 was found to be expressed in cell bodies and axons of isolated neurons (Fig 4, D) but could not be detected in surrounding supporting cells (Fig 4, E) .
TLR7 stimulation of HNECs and TGNs induces SP release
As TLR7 was mainly expressed on nerve fibers, which predominantly produce SP, and epithelial cells, which act as the first line of defense in the nose, the study focused on TLR7 to investigate the contribution of SP to viral recognition by TLRs in the airways. Stimulation of isolated TGNs by R-837 resulted in a significant and concentration-dependent increase in SP levels after 15 minutes (Fig 4, A) , which remained significantly high after 30 minutes and 4 hours (Fig 4, A and F) .
MNECs were similarly stimulated with the TLR7 agonist R-837. Stimulation resulted in a significant increase in SP levels after only 15 minutes compared with control values (Fig 4, B) . A concentration-dependent increase in SP levels was observed, and the levels of SP obtained after 15 minutes were maintained at 30 minutes and 4 hours (Fig 4, B and F) .
HNECs were stimulated with the TLR7 agonist R-837 and the TLR7/8 agonist R-848 to confirm whether this release occurs in human subjects. Stimulation by R-837 resulted in a significant increase in SP levels after only 15 minutes compared with control values (Fig 4, C) . A concentration-dependent increase in SP levels was observed, and SP levels obtained after 15 minutes were maintained at 30 minutes and 4 hours (Fig 4,  C and F) . Stimulation with R-848 resulted similarly in SP release, but the effect was less prominent. However, a significant effect was observed at an R-848 concentration of 100 mg/mL (Fig 4, C) .
Due to of the different seeding techniques used in the TGN, MNEC, and HNEC cultures, the release of SP was quantified as a concentration per 1000 cells. The results show that stimulation of TGNs resulted in 500-fold higher production of SP compared with stimulation of MNECs and HNECs (Fig 4, G) .
SP affects TLR expression on HNECs
The function of the immediate release of SP from the nasal epithelia and sensory neurons was subsequently assessed by stimulating HNECs with different concentrations of SP. Expression of NK1R was measured to confirm the ability for SP to activate epithelial cells. NK1R was found to be expressed on HNECs (Fig 5, A) . SP stimulation resulted in upregulation of TLR1, TLR3, TLR4, TLR7, and TLR9 (Fig 5, B-F) . TLR2, TLR5, TLR6, and TLR8 appeared to be unresponsive to stimulation with SP (see Fig E2 in this article' s Online Repository at www.jacionline.org). Exposure to SP increased expression of TLR1, TLR3, and TLR4 in a concentration-dependent manner (Fig 5, B-D) . The increase in expression reached statistical significance within 30 minutes at SP concentrations of 50 nmol/L and greater. On exposure to SP, the increase in TLR7 and TLR9 expression reached statistical significance at only 10 nmol/L SP, after which it plateaued: exposure to higher SP concentrations did not lead to further TLR expression (Fig 5, E and F) .
Expression of TLR4 in HNECs was imaged after SP stimulation to determine how TLRs were upregulated. In unstimulated HNECs TLR4 was located mainly intracellularly around the nucleus (Fig 6, A and C) . After SP stimulation, higher expression of TLR4 could be detected on the cell surface (Fig 6, B and D) . Some cells demonstrated polarized (white arrow) or punctate (yellow arrow) expression.
Cells were cultured in the presence of SP and its antagonist aprepitant to evaluate whether upregulation of TLRs was specific to SP. Expression of TLR1, TLR4, TLR7, and TLR9 remained at control levels (Fig 7, A, C, D, and E) . Comparatively, TLR3 upregulation was not blocked by aprepitant (Fig 7, B) .
DISCUSSION
The neuropeptide SP was once demonstrated to play a critical role in animal models of chronic airway inflammation. 2, 3 However, this was difficult to validate clinically, 8 suggesting an alternative role for this neuropeptide. The present study demonstrates that SP is released from epithelial cells and sensory neurons in the nasal mucosa in response to TLR7 stimulation. The released SP in turn rapidly upregulates TLR expression on epithelial cells. This suggests that SP plays a role in priming the innate immune system during viral infections.
SP production in response to airway viral infection is a well-established phenomenon, 11, 12 with evidence suggesting a role for SP in the symptoms of infection. 13 As viruses are primarily and initially recognized by TLRs, the present study was designed to investigate whether TLRs could contribute to the early production of SP during viral infection. Because TLR7 was almost exclusively found on nerve fibers, with an ability to produce SP, and epithelial cells, which act as the first line of defense, the study focused on the relationship between TLR7 and SP.
Stimulation with the TLR7 agonist R-837 and the TLR7/8 agonist R-848 resulted in rapid release of SP from sensory neurons, MNECs, and HNECs. Given that TLR8 has not been found to be expressed on HNECs, 21 the present results indicate that the observed SP increase was primarily related to TLR7 stimulation. Significantly, SP levels increased after just 15 minutes and were maintained after 4 hours, suggesting that both nasal epithelia and sensory neurons release SP in a single burst within minutes of TLR7 stimulation. Although previous studies have demonstrated that TLR agonists can heighten neuropeptide release by other stimulants (eg, capsaicin), 22 this is the first study to show that TLR stimulation can directly and rapidly trigger SP secretion.
SP was shown to be released from both sensory neurons and nasal epithelium in a concentration-dependent manner. However, the former release was found to be about 500 times higher than the latter, when the release was expressed in relation to the number of cells involved. Although this demonstrates a profound capability of neurons to produce SP, nasal epithelial cells are local and far outnumber neurons, indicating their powerful role of producing SP in the nasal mucosa. The mechanism through which this occurs is beyond the scope of this study but might be related to an interaction between TLR7 and transient receptor potential ankyrin 1 because activation of the latter is known to induce SP release. 23 TLR7 has also been shown to interact with transient receptor potential ankyrin 1 on the surfaces of sensory neurons, 24 as well as on airway epithelial cells. 25 The ability for both cell types to rapidly secrete SP in response to TLR stimulation and viral invasion represents a novel first-line defense mechanism for cells of the upper airway.
Neuropeptides have previously been identified as having immunomodulatory roles able to alter the expression of TLRs in certain cell types. 16, 26 For example, in a disease model setting treatment with vasoactive intestinal polypeptide alters TLR expression in the gut mucosa. 26 Comparatively, within 24 hours, SP is able to upregulate expression of TLR2 and TLR8 on human mast cells in vitro. 16 In our study HNECs demonstrated high NK1R expression, leading to the hypothesis that SP might have an influence on the innate host defense responses of nasal epithelial cells by altering TLR expression. (Fig 5, B) , TLR3 (Fig 5, C) , TLR4 (Fig 5, D) , TLR7 (Fig 5, E) , and TLR9 (Fig 5, F) after stimulation with SP or vehicle for 30 minutes (n 5 5). *P < .05 and **P < .01, comparing unstimulated versus stimulated cells. Values are means 6 SEMs.
Stimulation of HNECs with SP resulted in an increase in expression of TLR1, TLR3, TLR4, TLR7, and TLR9. Upregulation of all but TLR3 was demonstrated to be the result of interaction of SP with NK1R. As TLR3 was itself upregulated by the NK1R inhibitor aprepitant, an inhibition of TLR3 expression could not be verified. It is possible that other neurokinin 1 receptors are somewhat involved in SP-induced TLR3 upregulation.
Significantly, the increase in mucosal TLR expression was very rapid and evident after just 30 minutes of SP stimulation. Because of the speed at which the increased expression of TLRs occurs, it is likely a result of alterations in trafficking rather than de novo synthesis. 27 In line with this, stimulation of HNECs with SP resulted in movement of TLR4 from intracellular compartments close to the nucleus to the cell surface. It has been shown previously that respiratory epithelial cells express intracellular TLR4 located in pools in the Golgi complex, which is transferred to the cell surface within minutes after stimulation. 28, 29 Similarly, TLR3, TLR7, and TLR9 are trafficked from endoplasmic reticulum or Golgi pools to endosomes on stimulation. 30 Therefore, it is likely that the upregulation of TLRs seen in this study is due to SP-induced redistribution. Our results show that SP can be released from epithelial cells and sensory neurons in the nose within 15 minutes of TLR7 stimulation. Because neuropeptides are prepackaged in secretory vesicles, they are available for rapid secretion on cell stimulation. Neuropeptides are known to have a slow turnover rate, 27 indicating that widespread release of SP is an energyconsuming process. Furthermore, SP has a short half-life in tissues, ranging from seconds to tens of minutes. 31 The mechanism behind the short half-life is explained by the kinetics of enzymatic and/or chemical degradation in the extracellular environment, by binding to cells, and by the cellular internalization of SP. 32 Therefore our postulated release of SP in a single burst suggests a more efficient use of this mediator.
This study also demonstrates that SP induces upregulation of TLRs in the nasal epithelium and that upregulation of TLRs occurs at the protein level within 30 minutes of cell stimulation. Hence it appears that in the case of viral stimuli, SP is released promptly after activation of TLR7, which in turn causes TLRs to be upregulated. This rapidly prepares the epithelial cells against incoming viral antigens. SP is not continuously produced on TLR7 stimulation, and after the immediate upregulation of TLRs, the TLRs themselves take over, and inflammation proceeds along the traditional lines. Therefore neuropeptides can be designed for kickstarting the immune system, locally regulating or priming acute inflammation.
For the first time, the presented data show that the burst of neuronal and epithelial SP acts as an initial defensive response to viral stimuli in the upper airway, upregulating TLRs in the nasal epithelium and rapidly preparing the airway for pathogenic insult. In regard to the lower airway, previous studies have shown that circulating SP is upregulated in asthmatic patients who present with an exacerbation. 33 We have also shown that engagement of TLRs induces exacerbated hyperreactivity in a well-established murine model of asthma in an inflammation-independent manner. 34 This makes it tempting to suggest that the interplay between SP and TLRs is an important and novel mechanism not only preparing the nasal mucosa against incoming antigens but also inducing augmented hyperreactivity and dysregulated inflammation in virus-induced asthma exacerbation. Hence this might be a key pathway in the acute and local pathogendriven innate immune response, which is of major clinical importance.
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Key messages
d SP is rapidly released on viral detection by TLRs in the nasal mucosa.
d SP subsequently causes a prompt upregulation of mucosal TLRs, indicating a novel role for neuropeptides in innate immunity. 
